Table: Kobayashi Pharmaceutical - 6-MTH group results
Jul 31 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2018 Jun 30, 2017 Dec 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 72.68 67.31 163.00
(+8.0 pct) (+4.0 pct)
Operating 11.60 10.36 23.70
(+12.0 pct) (+3.4 pct)
Recurring 11.53 10.24 24.80
(+12.6 pct) (+2.5 pct)
Net 7.63 7.04 17.00
(+8.4 pct) (+7.2 pct)
EPS 96.58 yen 89.44 yen 215.33 yen
EPS Diluted 96.50 yen 89.31 yen
Ann Div 58.00 yen 61.00 yen
-Q2 div 31.00 yen 28.00 yen
-Q4 div 30.00 yen 30.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows